Oppenheimer analyst Andreas Argyrides initiated coverage of Korro Bio (KRRO) with an Outperform rating and $155 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO: